Literature DB >> 23508816

The risk factors for lymph node metastasis in early gastric cancer patients who underwent endoscopic resection: is the minimal lymph node dissection applicable? A retrospective study.

Sang Yong Son1, Ji Yeon Park, Keun Won Ryu, Bang Wool Eom, Hong Man Yoon, Soo Jeong Cho, Jong Yeul Lee, Chan Gyoo Kim, Jun Ho Lee, Myeong-Cherl Kook, Il Ju Choi, Young-Woo Kim.   

Abstract

PURPOSE: The purpose of this study was to identify risk factors associated with lymph node (LN) metastasis in early gastric cancer patients who underwent endoscopic resection (ER) and to evaluate the feasibility of minimal LN dissection in these patients.
METHODS: From January 2001 to March 2011, patients who underwent gastrectomy with lymphadenectomy due to the potential risk of LN metastasis after ER were enrolled at National Cancer Center, Korea. The incidence, risk factors, and distribution of LN metastasis were evaluated.
RESULTS: Of the 147 enrolled patients, the LN metastasis was identified in 12 patients (8.2%). The incidence of LN metastasis was not significantly increased in patients with submucosal invasion, lymphovascular invasion, and mixed undifferentiated histology [odds ratio (OR), 5.55, 1.349, and 0.387; 95% confidence interval (CI), 0.688-43.943, 0.405-4.494, and 0.081-1.84, respectively]. Tumor size more than 2 cm was significantly associated with LN metastasis (OR, 14.056; 95% CI, 1.76-112.267). The incidence of LN metastasis gradually increased from 3.2 to 20%, as number of risk factors increased (P = 0.019). LN metastasis was present primarily along the perigastric area in all except two patients (1.4%) with skip metastasis to extragastric area.
CONCLUSIONS: Standard surgery with at least D1 + LN dissection must be recommended for patients who proved to have risk factors for LN metastasis after ER, because the potential of skip metastasis is not negligible. Nevertheless, the minimal LN dissection, such as sentinel basin dissection, might be applied cautiously in patients with small-sized tumors after ER.

Entities:  

Mesh:

Year:  2013        PMID: 23508816     DOI: 10.1007/s00464-013-2901-z

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  24 in total

Review 1.  Diagnostic value of sentinel lymph node biopsy in gastric cancer: a meta-analysis.

Authors:  Zhen Wang; Zhi-Yong Dong; Jun-Qiang Chen; Jin-Lu Liu
Journal:  Ann Surg Oncol       Date:  2011-11-03       Impact factor: 5.344

2.  7th edition of the AJCC cancer staging manual: stomach.

Authors:  Kay Washington
Journal:  Ann Surg Oncol       Date:  2010-12       Impact factor: 5.344

3.  Clinicopathological significance of peritumoral lymphatic vessel density in gastric carcinoma.

Authors:  Peng Gao; Geng-Yin Zhou; Qing-Hui Zhang; Lei Xiang; Shun-Li Zhang; Chao Li; Yan-Lin Sun
Journal:  Cancer Lett       Date:  2008-03-04       Impact factor: 8.679

4.  Treatment strategy after non-curative endoscopic resection of early gastric cancer.

Authors:  I Oda; T Gotoda; M Sasako; T Sano; H Katai; T Fukagawa; T Shimoda; F Emura; D Saito
Journal:  Br J Surg       Date:  2008-12       Impact factor: 6.939

5.  Analysis of lymph node metastasis in early gastric cancer: rationale of limited surgery.

Authors:  K Kitamura; T Yamaguchi; H Taniguchi; A Hagiwara; K Sawai; T Takahashi
Journal:  J Surg Oncol       Date:  1997-01       Impact factor: 3.454

6.  Japanese classification of gastric carcinoma: 3rd English edition.

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

7.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

8.  Laparoscopic lymph node dissection after endoscopic submucosal dissection: a novel and minimally invasive approach to treating early-stage gastric cancer.

Authors:  Nobutsugu Abe; Toshiyuki Mori; Hirohisa Takeuchi; Takashi Yoshida; Atsuko Ohki; Hisayo Ueki; Osamu Yanagida; Tadahiko Masaki; Masanori Sugiyama; Yutaka Atomi
Journal:  Am J Surg       Date:  2005-09       Impact factor: 2.565

9.  Is gastrectomy mandatory for all residual or recurrent gastric cancer following endoscopic resection? A large-scale Korean multi-center study.

Authors:  Kyo Young Song; Woo Jin Hyung; Hyung Ho Kim; Sang Uk Han; Gyu Seok Cho; Seung Wan Ryu; Hyuk Joon Lee; Min Chan Kim
Journal:  J Surg Oncol       Date:  2008-07-01       Impact factor: 3.454

10.  Sentinel node mapping and skip metastases in patients with early gastric cancer.

Authors:  Sang Eok Lee; Jun Ho Lee; Keun Won Ryu; Soo Jeong Cho; Jong Yeul Lee; Chan Gyoo Kim; Il Ju Choi; Myung Cherl Kook; Byung-Ho Nam; Sook Ryun Park; Jong Seok Lee; Young-Woo Kim
Journal:  Ann Surg Oncol       Date:  2009-01-06       Impact factor: 5.344

View more
  34 in total

1.  Optimal management for patients not meeting the inclusion criteria after endoscopic submucosal dissection for gastric cancer.

Authors:  Takahiro Toyokawa; Masaichi Ohira; Hiroaki Tanaka; Hiroaki Minamino; Katsunobu Sakurai; Yasuaki Nagami; Naoshi Kubo; Atsushi Yamamoto; Koji Sano; Kazuya Muguruma; Kazunari Tominaga; Hiroko Nebiki; Yoshito Yamashita; Tetsuo Arakawa; Kosei Hirakawa
Journal:  Surg Endosc       Date:  2015-10-13       Impact factor: 4.584

2.  Risk stratification and predictive risk-scoring model for lymph node metastasis in early gastric cancer.

Authors:  Masau Sekiguchi; Ichiro Oda; Hirokazu Taniguchi; Haruhisa Suzuki; Shinji Morita; Takeo Fukagawa; Shigeki Sekine; Ryoji Kushima; Hitoshi Katai
Journal:  J Gastroenterol       Date:  2016-02-16       Impact factor: 7.527

3.  Long-term clinical outcomes of endoscopic resection for early gastric cancer.

Authors:  Jeongmin Choi; Sang Gyun Kim; Jong Pil Im; Joo Sung Kim; Hyun Chae Jung
Journal:  Surg Endosc       Date:  2014-08-27       Impact factor: 4.584

4.  The role of tumor size in surgical decision making after endoscopic resection for early gastric cancer.

Authors:  Hae Won Kim; Yoo Jin Lee; Jie-Hyun Kim; Jae Jun Park; Young Hoon Youn; Hyojin Park; Jong Won Kim; Seung Ho Choi; Sung Hoon Noh
Journal:  Surg Endosc       Date:  2015-10-20       Impact factor: 4.584

5.  Predictors of lymph node metastasis in patients with non-curative endoscopic resection of early gastric cancer.

Authors:  Hyo-Joon Yang; Sang Gyun Kim; Joo Hyun Lim; Jeongmin Choi; Jong Pil Im; Joo Sung Kim; Woo Ho Kim; Hyun Chae Jung
Journal:  Surg Endosc       Date:  2014-08-30       Impact factor: 4.584

6.  Prognostic role of lymph node metastasis in early gastric cancer.

Authors:  Zhixue Zheng; Yiqiang Liu; Zhaode Bu; Lianhai Zhang; Ziyu Li; Hong Du; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2014-04       Impact factor: 5.087

Review 7.  Quality in upper gastrointestinal endoscopic submucosal dissection.

Authors:  Flaminia Purchiaroni; Guido Costamagna; Cesare Hassan
Journal:  Ann Transl Med       Date:  2018-07

8.  Risk factors for lymph node metastasis and long-term outcomes of patients with early gastric cancer after non-curative endoscopic submucosal dissection.

Authors:  Noboru Kawata; Naomi Kakushima; Kohei Takizawa; Masaki Tanaka; Rie Makuuchi; Masanori Tokunaga; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Takashi Sugino; Kimihide Kusafuka; Tadakazu Shimoda; Takashi Nakajima; Masanori Terashima; Hiroyuki Ono
Journal:  Surg Endosc       Date:  2016-08-05       Impact factor: 4.584

9.  Additional surgery for non-curative resection after endoscopic submucosal dissection for gastric cancer: a retrospective analysis of 200 cases.

Authors:  Hideki Sunagawa; Takahiro Kinoshita; Akio Kaito; Hidehito Shibasaki; Kazuhiro Kaneko; Atsushi Ochiai; Atsushi Ohtsu; Toshirou Nishida
Journal:  Surg Today       Date:  2016-05-18       Impact factor: 2.549

10.  Predictive factors for lymph node metastasis in additional gastrectomy after endoscopic resection of cT1aN0 gastric cancer.

Authors:  Satoru Ishii; Keishi Yamashita; Hiroshi Kato; Nobuyuki Nishizawa; Hideki Ushiku; Hiroaki Mieno; Hiromitu Moriya; Kei Hosoda; Natuya Katada; Shiro Kikuchi; Satoshi Tanabe; Wasaburo Koizumi; Makoto Saegusa; Masahiko Watanabe
Journal:  Surg Today       Date:  2015-12-10       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.